A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

Trial Details

NCT ID

NCT07841925

Phase

PHASE1 / PHASE2

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Status

RECRUITING

Cancer Type

Melanoma

Interventions

• BL-M08D1

Locations (sample)

• Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

• Voluntarily sign the informed consent form and comply with protocol requirements;
• No restriction on gender;
• Age: ≥18 years and ≤75 years;
• Expected survival time ≥3 months;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.